Share This Article:

Quantitative Computerized Tomography (QCT) versus Dual X-Ray Absorptiometry (DXA) in the Assessment of Bone Mineral Density of HIV-1 Infected Children

Full-Text HTML Download Download as PDF (Size:166KB) PP. 306-311
DOI: 10.4236/wja.2012.24041    3,321 Downloads   5,292 Views  

ABSTRACT

Bone studies of HIV-infected children using dual X-ray absorptiometry (DXA) suggest bone mineral density (BMD) abnormalities. Pediatric studies are often performed using DXA instead of computed tomography (CT), which accounts for 3-dimensional differences in bone size of growing children. We evaluated whether CT would match DXA measurements in this population. For this purpose, the BMD of 16 perinatally HIV-infected patients, ages 6 to 22 was assessed. Subjects were matched by age, gender, and race to controls. BMD was assessed via DXA and QCT. Clinical anthropometric data, body mass index, immunologic and virologic parameters and laboratory markers for osteoblastic and osteoclastic activity were performed. No statistically significant differences in age and anthropometric parameters between subjects and controls were found. Individual CT and DXA z-scores were significantly different when subjects were evaluated as a group (p = 0.0002) or when males and females were analyzed independently (p = 0.001 and 0.03). DXA z-scores were below 1 SD, while CT z-scores were above the mean. 31% of subjects were identified as having poor bone mineralization by DXA while none had osteopenia/osteoporosis by CT. There was no correlation between immunologic/virologic parameters and BMD by either method. Increased osteoclastic activity was noted in 10 patients receiving tenofovir. In summary, decreased BMD diagnosed by DXA in pediatric HIV-infected subjects was not confirmed by CT. Increased bone turnover in patients on tenofovir was suggested by laboratory markers. Prospective studies using CT as the imaging standard are needed for evaluation of bone mineral changes in HIV-infected children.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

J. Lin, M. Ines Boechat, J. G. Deville, D. Gilsanz, R. Stiehm, V. Gilsanz, I. Salusky and K. Nielsen-Saines, "Quantitative Computerized Tomography (QCT) versus Dual X-Ray Absorptiometry (DXA) in the Assessment of Bone Mineral Density of HIV-1 Infected Children," World Journal of AIDS, Vol. 2 No. 4, 2012, pp. 306-311. doi: 10.4236/wja.2012.24041.

References

[1] The Writing Group for the ICSD Position Development Conference, “Diagnosis of Osteoporosis in Men, Premenopausal Women, and Children,” Journal of Clinical Densitometry, Vol. 7, No. 1, 2004, pp. 17-26.
[2] R. I. Gafni and J. Baron, “Overdiagnosis of Osteoporosis in Children Due to Misinterpretation of Dual-Energy X-Ray Absorptiometry (DEXA),” Journal of Pediatrics, Vol. 144, No. 2, 2004, pp. 253-257. doi:10.1016/j.jpeds.2003.08.054
[3] T. A. L. Wren, X. Liu, P. Pitukcheewanont and V. Gilsanz, “Bone Densitometry in Pediatric Populations: Discrepancies in the Diagnosis of Osteoporosis by DXA and CT,” Journal of Pediatrics, Vol. 146, No. 6, 2005, pp. 776-779. doi:10.1016/j.jpeds.2005.01.028
[4] S. M. Arpadi, M. Horlick, J. Thornton, P. A. Cuff, J. Wang and D. P. Kotler, “Bone Mineral Content Is Lower in Prepubertal HIV-Infected Children,” Journal of Acquired Immune Deficiency Syndrome, Vol. 19, 2002, 450-454.
[5] M. J. Bolland, A. B. Grey, G. D. Gamble and I. R. Reid, “Low Body Weight Mediates the Relationship between HIV-Infection and Low Bone Mineral Density: A Meta-Analysis,” Journal of Clinical Endocrinology and Metabolism, Vol. 92, No. 12, 2007, pp. 4522-4528. doi:10.1210/jc.2007-1660
[6] J. H. Arnsten, R. Freeman, A. A. Howard, M. Floris-Moore, Y. Lo and R. S. Klein, “Decreased Bone Mineral Density and Increased Fracture Risk in Aging Men with or at Risk for HIV Infection,” AIDS, Vol. 21, No. 5, 2007, pp. 617-623. doi:10.1097/QAD.0b013e3280148c05
[7] J. B. Purdy, R. I. Gafni, J.C. Reynolds, S. Zeichner and R. Hazra, “Decreased Bone Mineral Density with Off-Label Use of Tenofovir in Children and Adolescents Infected with Human Immunodeficiency Virus,” Journal of Pediatrics, Vol. 152, No. 4, 2008, pp. 582-584. doi:10.1016/j.jpeds.2007.12.020
[8] S. Mora, I. Zamproni, S. Beccio, R. Bianchi, V. Giacomet and A. Vigano, “Longitudinal Changes of Bone Mineral Density and Metabolism in Antiretroviral-Treated Human Immunodeficiency Virus-Infected Children,” Journal of Clinical Endocrinology & Metabolism, Vol. 89, No. 1, 2004, pp. 24-28. doi:10.1210/jc.2003-030767
[9] S. Landonio, T. Quirino, P. Bonfanti, et al., “Osteopenia and Osteoporosis in HIV+ Patients, Untreated or Receiving HAART,” Biomedical Pharmacotherapy, Vol. 58, No. 9, 2004, pp. 505-508. doi:10.1016/j.biopha.2004.08.019
[10] S. E. Dolan, J. S. Huang, K. M. Killilea, M. P. Sullivan, N. Aliabadi and S. Grinspoon, “Reduced Bone Density in HIV-Infected Women,” AIDS, Vol. 18, No. 3, 2004, pp. 475-483. doi:10.1097/00002030-200402200-00014
[11] V. Gilsanz, “Bone Density in Children: A Review of the Available Techniques and Indications,” European Journal of Radiology, Vol. 26, No. 2, 1998, pp. 177-182. doi:10.1016/S0720-048X(97)00093-4
[12] T. N. Hangartner and C. C. Johnston, “Influence of Fat on Bone Measurements with Dual-Energy Absorptiometry,” Bone and Mineral, Vol. 9, No. 1, 1990, pp. 71-81. doi:10.1016/0169-6009(90)90101-K
[13] V. Gilsanz, F. J. Perez, P. P. Campbell, F. J. Dorey, D. C. Lee and T. A. Wren, “Quantitative CT Reference Values for Vertebral Trabecular Bone Density in Children and Young Adults,” Radiology, Vol. 250, 2009, pp. 222-227. doi:10.1148/radiol.2493080206
[14] T. Hangartner and V. Gilsanz, “Evaluation of Cortical Bone by Computed Tomography,” Journal of Bone Mineralization Research, Vol. 11, 1996, pp. 1518-1525.
[15] V. Gilsanz, M. I. Boechat, T. F. Roe, M. L. Loro, J. W. Sayre and W. G. Goodman, “Gender Differences in Vertebral Body Sizes in Children and Adolescents,” Radiology, Vol. 190, No. 3, 1994, pp. 673-677.
[16] W. Kalender, “Effective Dose Values in Bone Mineral Measurements by Photon Absorptiometry and Computed Tomography,” Osteoporosis International, Vol. 2, No. 2, 1992, pp. 82-87. doi:10.1007/BF01623841
[17] C. E. Cann, “Why, When and How to Measure Bone Mass: A Guide for the Beginning User,” In: G. D. Frey, M. V. Yester, Eds., Expanding the Role of Medical Physics in Nuclear Medicine, American Institute of Physics Publishing, New York, 1991, pp. 250-285.
[18] S. Mora, L. Bachrach and V. Gilsanz, “Noninvasive Techniques for Bone Mass Measurement,” San Diego Academic Press, San Diego, 2003.
[19] M. B. Leonard, K. J. Propert, B. S. Zemel, V. A. Stallings and H. I. Feldman, “Discrepancies in Pediatric Bone Mineral Density Reference Data: Potential for Misdiagnosis of Osteopenia,” Journal of Pediatrics, Vol. 135, No. 2, 1999, pp. 182-188. doi:10.1016/S0022-3476(99)70020-X
[20] A. Prentice, T. J. Parsons and T. J. Cole, “Uncritical Use of Bone Mineral Density in Absorptiometry May Lead to Size-Related Artifacts in the Identification of Bone Mineral Determinants,” American Journal of Clinical Nutrition, Vol. 60, No. 6, 1994, pp. 837-842.
[21] H. J. Kalkwarf, V. Gilsanz, J. M. Lappe, et al., “Tracking of Bone Mass and Density during Childhood and Adolescence,” Journal of Clinical Endocrinology and Metabolism, Vol. 95, No. 4, 2010, pp. 1690-1698. doi:10.1210/jc.2009-2319

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.